Quality of life in Black and Mixed-ethnicity men with prostate cancer
Uses questionnaires to learn how prostate cancer affects Black and Mixed-ethnicity men.
Key facts
- Who runs it
- Institute of Cancer Research, United Kingdom
- Where
- Rotterdam, NetherlandsSee the site
- Trial code
- Registry title
- The BALANCE Study: BlAck and Mixed Men's Lived Experience With Prostate cANCEr-Diversity in Prostate Cancer PROMS Study
- Status
- Recruiting
- People taking part
- 800 people, planned
- Started
- 21 Aug 2026
- Expected to end
- Dec 2027
- Type of study
- Observational
- Treatments tested
- Patient Reported Outcome Measurements (PROMs)
- Record updated
- 27 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult men with prostate cancer who are of Black African, Black African-Caribbean or Mixed Black ancestry. They fill in a questionnaire about their quality of life.
- Age
- 18 years or older
- Sex
- Men (assigned male at birth)
- Disease stage
- Diagnosed with prostate cancer. No stage is named.
Main reasons for not taking part
- No diagnosis of prostate cancer
- Unable to give consent
- Assigned female at birth
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Age ≥ 18 years
- Be of either:; Black African ancestry; OR; Black African-Caribbean ancestry; OR; Mixed Black ancestry
- Diagnosed with PCa
- Assigned male at birth
- Participants with access to digital devices (smartphones, tablets, computers) or able to complete hardcopy versions of the survey
- Participants willing to participate and provide informed consent
Who cannot take part
- A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Participants having no diagnosis of PCa
- Participants unable to provide consent
- Participants assigned female at birth
Where in Netherlands
- The Erasmus MCRotterdam, NetherlandsContact: Dr Lionne Venderbos, PhDTaking people
About the trial
What the trial wants to find out
The BALANCE study is a prospective Patient Reported Outcomes Measures (PROMs) study developed to look at the quality of life (QoL) of patients diagnosed with prostate cancer (PCa) in communities underrepresented in research, especially Black men of African, and Caribbean ancestry as well as men of Mixed ethnicity. This study will also investigate various PCa treatment types and their mental health impact on patients. There is a lack of research on PROMs in diverse populations. Collecting PROMs specifically from Black men and individuals with prostates who are receiving/have received treatment for PCa is essential for understanding their unique post-treatment experiences. The insights are vital to addressing documented disparities, tailoring supportive care and ultimately providing equitable health outcomes.
Read full original descriptionShow less
Participants in this study will be asked to complete a questionnaire (either electronically or hardcopy) to share their insights following their PCa diagnosis.
The group in the trial
- Black men and those of Mixed ethnicity.
Black men of African, and Caribbean ancestry as well as men of Mixed ethnicity.
Treatment: Patient Reported Outcome Measurements (PROMs)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- BlAck and Mixed Men's Lived Experience With Prostate cANCEr - Diversity in Prostate Cancer PROMS Study
- Plain-language title
- Quality of life in Black and Mixed-ethnicity men with prostate cancerGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Record updated
- 27 October 2026